Given that lipid-driven inflammation is one of the key mechanisms of atherosclerosis, it is possible that macrophage OLFR2 activation may has a similar pathophysiological role in other diseases associated with lipid-driven inflammation, such as diabetes, obesity, cancer, neurodegeneration, and heart failure with preserved ejection fraction. Here, OR2H2 is linked to atherosclerosis.